[Cholestatic jaundice following disseminated intravascular coagulation ("shock-liver") (author's transl)].
Recently we gained increasing evidence of the fact that cholostatic syndromes in young infants are frequently associated with preceeding shock and disseminated intravascular coagulation.  This is illustrated by the case of a 4 weeks-old male infant with urosepticemia due to E. coli, which was successfully treated with additional streptokinase.  Therefore, in the age-group of early infancy we have to pay attention to the liver as a potential shock-organ similar to the well known shock organs such as kidneys, lungs, skin and brain.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002779:Cholestasis / Q000097:blood / Q000209:etiology*; D004211:Disseminated Intravascular Coagulation / Q000150:complications* / Q000188:drug therapy; D004927:Escherichia coli Infections / Q000150:complications; D005860:Germany, West; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases; D008297:Male; D012189:Retrospective Studies; D012769:Shock / Q000150:complications*; D013300:Streptokinase / Q000627:therapeutic use; D014552:Urinary Tract Infections / Q000097:blood / Q000150:complications / Q000188:drug therapy
D000900:Anti-Bacterial Agents; D006493:Heparin; D013300:Streptokinase
Cholostatischer Ikterus nach disseminierter intravasaler Gerinnung ("Schockleber")